D. Lynn Kirkpatrick
Chief Executive Officer
Dr. Kirkpatrick has focused her entire career on drug discovery and development. Former Professor of Chemistry and Biochemistry in Canada, she has co-founded two start up companies and successfully brought three novel cancer drug candidates into human clinical trails. Following the acquisition of her first company, by Biomira Inc., (Oncothyreon) in 2006, Dr. Kirkpatrick took the role as the Chief Scientific Officer of the merged company. She became President and CEO of Ensysce Biosciences Inc. in January 2009. Dr. Kirkpatrick received her PhD from the University of Saskatchewan and completed a post-doctoral fellowship at Yale University School of Medicine. She has published extensively in the area of targeted cancer drug discovery and development and holds numerous patents for novel targeted cancer drugs and SWCNT delivery technology.
Chief Business Officer
Richard Wright has held positions in investment banking, venture capital, and intellectual property advisory. Most recently, Richard has been Managing Director of Newstock Capital an intellectual property investment bank advising investment firms, hedge funds, and multi-national banks on patent financing, investing, and divestitures in the healthcare space. Prior to Newstock, Richard started and managed a worldwide intellectual property healthcare investment fund for General Electric. In addition he co-founded an immunology biotech company which was later sold to a private equity concern, and was involved with a patent advisory firm in Philadelphia that was sold to investment bank Boenning & Scattergood. Richard has an MSE in biotechnology/technology management from the University of Pennsylvania School of Engineering & Applied Sciences and the Wharton School of Business (EMTM), and a MBA from the London School of Economics (TRIUM).
Chief Financial Officer
Kurt Schmidt has 30+ years experience in entrepreneurial environments with a focus on start-up and early stage operations. He has been responsible for multiple facets of leadership including strategy, finance, operations and business expansion, by collaborating with Boards and CEO’s. With professional experience in diverse industries including Biotech, Technology and FMCG, Mr. Schmidt has lived and worked in 3 countries (USA, Netherlands, France) and conducted business on 6 continents, providing him an ability to understand and operate in various cultures. He has a BSBA in Business Administration from Franklin University and an MBA from Pepperdine University, The George L Graziadio School of Business and Management.